Oncology Models | Charles River Discovery Services

Radiation 

Charles River Discovery Services is licensed to carry out biodistribution studies with C14- and H3-labeled molecules. Biodistribution studies with C- and H-labeled molecules help determine the targeting and tumor specificity of a test agent. On-site determination of radiolabeled levels in samples is possible.

We also have the capability of administering radiation as a therapy using a Faxitron Model CP-160 instrument. This capability enables the use of radiation for:

  • Combination radiation/chemotherapy
  • Myeloablation
  • In vitro applications


For more information about our radiation services, please contact us at askcharlesriver@crl.com.

Discover the full range of Charles River Products and Services
The Source

For more information, contact us at:

+33 (0)4 74 01 69 69
askcharlesriver@crl.com

view all

News & Events

view all
mai 14 - New Models for Evaluating COPD or ...
mai 11 - Expert Safety Testing to Accelerat...
juin 14-juin 14 - Hørsholm, Denmark - Biotech Outsourcing Strategies (chemistry, manufa...
juin 02-juin 05 - Vancouver, British Columbia - CALAS
juin 05-juin 05 - King of Prussia, Pennsylvania - Assessment of Immunomodulation for Bi...
juin 05-juin 08 - Germain sur l’Arbresle, France - Charles River LAL Seminar Series
view all
Scientist I Wilmington, MA, US

Charles River Laboratories, Inc.